Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms Forms Data Management Alliance With Nonprofit CureDuchenne

NEW YORK — BC Platforms said on Friday that it will assist CureDuchenne, a nonprofit focused on Duchenne muscular dystrophy research, with its data management and sharing efforts.

Through the collaboration, CureDuchenne has integrated BC Platforms' Discovery and Research Platform, or DRP, for data integration, management, analysis, and sharing into its CureDuchenne Link global data hub.

Just launched, the data hub provides scientists and drug developers with access to Duchenne and Becker muscular dystrophy data and biosamples, according to Newport Beach, California-based CureDuchenne.

As part of its alliance with CureDuchenne, BC Platforms said it will also support data repository storage, as well as data management and analysis tools for genomic, phenotypic, sample, and whole-genome sequencing data.

BC's DRP "enables distributed analysis models and scales tertiary analysis of genomic and clinical data combined," Nino da Silva, deputy managing director at BC Platforms, said in a statement. "The repository will provide an invaluable single, unified, HIPAA-compliant platform accessible by clinicians, researchers, and drug developers to deliver novel insights into drug development."

Earlier this year, Zurich-based BC Platforms signed an agreement with Genomenon to merge technologies for rare disease diagnostics and research.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.